Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Jazz Pharmaceuticals Raises FY2025 GAAP EPS Guidance from $(9.25)-$(7.50) to $(7.10)-$(5.20) vs $(7.76) Est

Author: Benzinga Newsdesk | November 05, 2025 04:18pm

Jazz Pharmaceuticals (NASDAQ:JAZZ) raises FY2025 GAAP EPS guidance from $(9.25)-$(7.50) to $(7.10)-$(5.20) vs $(7.76) analyst estimate..

Posted In: JAZZ